| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 34.73%3,608.00 | 2,678.00 | 2,778.00 | 4,095.00 | 3,096.00 |
| Cost Of Revenue | 8.95%633.00 | 581.00 | 487.00 | 549.00 | 544.00 |
5.33%672.00 | 638.00 | - | - | - | |
| Research and Development | 5.33%672.00 | 638.00 | - | - | - |
| Costs And Expenses | 9.95%2,850.00 | 2,592.00 | 2,509.00 | 2,470.00 | 2,484.00 |
| Operating Income/Loss | 781.40%758.00 | 86.00 | 269.00 | 1,625.00 | 612.00 |
| Income/Loss From Continuing Operations Before Tax | 219.22%897.00 | 281.00 | 393.00 | 1,792.00 | 779.00 |
| Income Tax Expense/Benefit | 33.06%81.00 | 121.00 | 52.00 | 418.00 | 137.00 |
410.00%816.00 | 160.00 | 341.00 | 1,374.00 | 642.00 | |
| Attributable To Parent | 410.00%816.00 | 160.00 | 341.00 | 1,374.00 | 642.00 |
| Available To Common Stockholders, Basic | 410.00%816.00 | 160.00 | 341.00 | 1,374.00 | 642.00 |
| Basic Average Shares | 1.00%592.00 | 598.00 | -3.00 | 611.00 | 615.00 |
| Diluted Average Shares | 1.81%597.00 | 608.00 | -3.00 | 621.00 | 626.00 |